Open Sustainability Index Logo
Report Data

Company

Novartis

2022
Quick facts
9,272,100
Emissions (ton CO₂e)
50,950
Revenue (M USD)
181.98
Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Novartis reported a total of 9,272,100 ton CO₂e, and a net revenue of 50,950 M USD, resulting in a emissions intensity of 181.98 t CO₂e / M USD.

Targets

Base year:

2016

Target year:

2030

Reduction:

0.35

Classification:

 Well-below 2°C

Swiss multinational pharmaceutical company Novartis commits to reduce absolute scope 1, 2 and 3 GHG emissions 35% by 2030 from a 2016 base-year.

Emissions, Revenue & Intensity

20202021202201,000,0002,000,0003,000,0004,000,0005,000,0006,000,0007,000,0008,000,0009,000,00010,000,000t CO₂05,00010,00015,00020,00025,00030,00035,00040,00045,00050,00055,000M USD

Emissions, Target & Trend

2020202120222023202420252026202720282029203001,000,0002,000,0003,000,0004,000,0005,000,0006,000,0007,000,0008,000,0009,000,00010,000,000t CO₂
Revenue202020212022
Net Revenue (M USD)48,60051,63050,950
Revenue Source
Emissions Overview202020212022
Total Emissions - Market Based (t CO₂e)
Emissions Intensity (t CO₂e / M USD)16.78153.71181.98
Cradle-to-gate Intensity (t CO₂e / M USD)
Emissions Details202020212022
Scope 1396,400352,800347,200
Scope 2
Scope 2 - Location Based
Scope 2 - Market Based
Scope 2 - Not specified392,200292,700154,900
Scope 327,0007,290,4008,770,000
Upstream Emissions
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions815,6007,935,9009,272,100
Emission Source
Licensed under CC BY-SA 4.0